May 24, 2022 / 02:45PM GMT
Gavin Fernandez -
Good morning, everyone. Thank you all for attending, and thank you for all those at home watching live. Hope you all enjoyed your breakfast and all that, and the speakers so far.
My name is Gavin Fernandez, and I'm an analyst on the UBS Healthcare team. I'm excited to introduce PureTech, a biotech company that develops and commercializes therapies for conditions with limited or no existing treatment options. Following this presentation, we will have a moderated Q&A session. But for now, PureTech. And George, thank you. Go ahead.
George Farmer - PureTech Health plc - CFO
Great. Thanks for the introduction, Gavin. I'm George Farmer, Chief Financial Officer of PureTech. I'd like to thank the UBS for involving us in this conference today and for the opportunity to present, and I welcome everyone in the audience and on the webcast.
During this presentation, we will be making some forward-looking statements, and I ask that you refer to our SEC filings available at sec.gov for a discussion of potential risks and uncertainties. All
PureTech Health PLC at UBS Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
